Ufovax is Biotechnology in United States that focus on provider business. Founded in 2018. They cover business area such as provider, b-cell, preventive vaccine, challenge disease, patient, HIV, RSV/hMPV, Ebola/Marburg, Lassa, coronaviruse, SARS-CoV, MERS-CoV, HCV, ZIKV, DENV, non-viral disease, Malaria, Tuberculosis.
2018
( 6 years old in 2024 )
Provider
-
3801 Kennett Pike
Suite. A101, #4482
Wilmington, DE 19807
United States
Private
providerb-cellpreventive vaccinechallenge diseasepatientHIVRSV/hMPVEbola/MarburgLassacoronaviruseSARS-CoVMERS-CoVHCVZIKVDENVnon-viral diseaseMalariaTuberculosis
* We use standard office opening hours in near Ufovax's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ufovax is Biotechnology business from United States that founded in 2018 (6 years old in 2024), Ufovax business is focusing on Provider.
Ufovax headquarter office and corporate office address is located in 3801 Kennett Pike Suite. A101, #4482 Wilmington, DE 19807 United States.
Ufovax was founded in United States.
In 2024, Ufovax is currently focus on provider sector.
Above is snippet of Google Trends for "provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ufovax, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
